Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
boston
boston blog main
boston top stories
2
×
deals
life sciences
national blog main
bayer
biontech
biotech
boehringer ingelheim
clinical trials
cronos group
curevac
eli lilly
ginkgo bioworks
hyperammonemia
infectious diseases
james collins
john shiver
liver diseases
moderna therapeutics
mrna
neurological diseases
new york blog main
new york top stories
phenylketonuria
san francisco blog main
san francisco top stories
sanofi
synlogic
timothy lu
translate bio
vaccines
What
medicines
synthetic
2
×
bacteria
bets
bio
biology
bioworks
called
cancer
comes
companies
company
comprised
cut
date
deal
developer
effective
engineered
enticed
evidence
ginkgo
hasn’t
lands
latest
living
messenger
molecules
mrna
multiple
new
pharmaceutical
primarily
promise
proven
ramp
rna
sanofi
second
source
Language
Current search:
synthetic
×
" boston top stories "
×
@xconomy.com
4 years ago
Synlogic Lands $80M from Ginkgo to Ramp Up “Living Medicines” R&D
@xconomy.com
5 years ago
With $45M Translate Bio Deal, Sanofi Bets Again on mRNA Vaccines